Latest news with #OxfordAcademic
Android Authority
15-05-2025
- Health
- Android Authority
Take off your tinfoil hat: Exposure to 5G doesn't alter your genes, new study finds
TL;DR A new study found no genetic changes in human cells exposed to 5G radiation, even at high intensities. Researchers ruled out heating effects, confirming previous claims of harm were likely due to temperature, not EMF. 5G waves can't penetrate deep into the skin, and aren't scrambling your DNA. The 5G conspiracy crowd has been banging their drum for years, but scientists have now directly tested their central claims. In a useful but unsurprising result, a new 5G study found that blasting human skin cells with the radiation doesn't do anything to your genes. The peer-reviewed study, published in PNAS Nexus via Oxford Academic, exposed cultured human skin cells to 5G electromagnetic fields at two common frequencies: 27 GHz and 40.5 GHz. The cells were subjected to this radiation at intensities up to 10 times the current safety limits for both two-hour and 48-hour periods. The result was no changes in gene expression or alterations in DNA methylation — in other words, nothing. 5G frequencies are too low to damage DNA. This isn't just a case of not finding much or narrowing the possible harm. The researchers took great care to rule out heat as a confounding factor, which has skewed the few isolated studies that reported apparent effects and fueled the conspiracy. By carefully managing temperature and isolating the electromagnetic exposure, they confirmed that any changes seen in past studies were likely caused by warming and not the EMF itself. In summary, the energy of 5G frequencies is too low to ionize atoms or break molecular bonds, which means it can't damage DNA. Not even a little. The study also found these signals don't even make it past the surface — 5G waves can only penetrate a matter of millimeters into your skin. So even if they were dangerous, which the study found they're not, they're not getting deep enough to start altering your brain or internal organs. Of course, conspiracy theorists are rarely shaken from their beliefs by a forensic and peer-reviewed 5G study such as this one. It'll no doubt be branded as some fake news government propaganda. People are welcome to wear a tinfoil hat if it makes them feel safer, but they can't say the science is on their side. Got a tip? Talk to us! Email our staff at Email our staff at news@ . You can stay anonymous or get credit for the info, it's your choice.
Time of India
27-04-2025
- Health
- Time of India
‘Extended resection lowers Lynch-related cancer risk'
Ahmedabad: A global research comprising of 8,438 patients suffering from colorectal cancer caused by Lynch Syndrome has indicated pathways for ensuring less chances recurrence. Tired of too many ads? go ad free now A cohort from Ahmedabad represented India in the study. Lynch Syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is the most common hereditary cancer condition that significantly increases the risk of developing colorectal cancer and other cancers. The condition often affects multiple generations, and in the Indian context, some studies estimate the prevalence to be one in 300 persons. More importantly, about 10-15% of colorectal cancers in India are caused by the condition compared to 2-10% in Western countries. The cancer has a high relapse rate of 17-50% in later stages. The study, ' Metachronous Colorectal Cancer Risks After Extended or Segmental Resection in MLH1, MSH2, and MSH6 Lynch Syndrome: Multicentre Study from the Prospective Lynch Syndrome Database,' was recently published in the British Journal of Surgery (BJS) by Oxford Academic. One of the authors of the study is Dr Harsh Sheth from FRIGE Institute of Human Genetics, Ahmedabad. "It is one of the biggest studies in connection with Lynch Syndrome, comprising over 65,000 person-year follow-ups and surgical data of 908 patients. The study started with the question of what is the best surgical approach after the first tumour – should the onco surgeons go for segmental resection or extended colectomy to reduce chances of relapse," said Dr Sheth. Tired of too many ads? go ad free now He added that the study's findings indicate an equal or higher risk of developing metachronous colorectal cancer for those who already have a history. It challenges the earlier notion that screening and resection are enough. " Extended resection significantly reduces the risk of metachronous cancer (across all Lynch Syndrome genes) compared to segmental resection. There is no survival benefit in either surgery group, but there are benefits in fewer operative procedures, reduced surveillance burden, and better quality of life," said Dr Sheth. The take-home message, said experts, for the surgical guidelines is to ensure that if Lynch Syndrome is detected pre-operatively, the chances of metachronous cancer should be discussed.
